- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04377737
Incidence of Covid-19 in School Children (COVIDECOLE)
Incidence of Covid-19 in School Children During the Pandemic Period in Nice
The Coronavirus disease 2019 (COVID-19) is causing a global pandemic with high morbidity and mortality among adults and mainly the elderly. Children seem to be little or not affected by this infection. It is estimated that children could be asymptomatic or pauci-symptomatic carriers and thus be vectors of the disease. This is why measures to close schools and confine populations have been decreed in a large number of countries, including France. However, there are only a few data on the prevalence of COVID19 disease in children. The deconfinement strategy depends on data on the prevalence of the disease, especially in children.
Investigators propose to evaluate the incidence of Covid-19 in preschool and elementary schools children in the city of Nice (South of France) during the pandemic period using a local prospective study of 914 children
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The Coronavirus disease 2019 (COVID-19) is causing a global pandemic with high morbidity and mortality among adults and mainly the elderly. Children seem to be little or not affected by this infection. It is estimated that children could be asymptomatic or pauci-symptomatic carriers and thus be vectors of the disease. However, the role of the children in the spread of COVID-19 injection remains unclear.
Measures to close schools and to confine populations have been decreed in a large number of countries, including France. This decision has been based on epidemiologic data of other viral infections having droplet transmission and on data of Middle East Respiratory Syndrome-related coronavirus (MERS-CoV) asymptomatic portage.
Furthermore, there are only a few data on the prevalence of COVID19 disease in children. The deconfinement strategy depends on data on the prevalence of the disease, especially in children.
Therefore, investigators propose to evaluate the incidence of Covid-19 in preschool and elementary schools children in the city of Nice (South of France) during the pandemic period using a local prospective study of 914 children.
This study will start on 11th May 2020, date of school reopening, in order to collect epidemiologic data about Covid-19 carriage among schoolers and to support governmental strategy for the new school year in September 2020.
Studietyp
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Nice, Frankrike
- Hôpitaux Pédiatrique de Nice CHU Lenval
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
Age ranging from 3 to 10 years old
- Children attending to school in Nice
- Informed consent
- French insurance subscribed
Exclusion Criteria:
- Refusal to participate from the parents or the child
- Bleeding disorders
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Diagnostisk
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Övrig: RT-PCR Covid-19
|
estimation of the prevalence of positive rt-PCR in school children during the pandemic period
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
evaluation of the prevalence of positive real-time-polymerase chain reaction (rt-PCR) in school children during the pandemic period in Nice
Tidsram: at 42 days
|
measure by two rt-PCR COVID-19 tests regardless the serological status of the child
|
at 42 days
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
evaluation of the serological prevalence of the Covid-19 infection
Tidsram: at inclusion and at 42 days
|
measure by two serological COVID-19 test (IgG and/or IgM)
|
at inclusion and at 42 days
|
evaluation of the COVID-19 reinfection among seropositive children at the inclusion time
Tidsram: at inclusion and at 42 days
|
measure by two serological COVID-19 test (IgG and/or IgM)
|
at inclusion and at 42 days
|
evaluation of the prevalence of positive rt-PCR of other respiratory viruses (including others coronavirus)
Tidsram: at 42 days
|
positivity of rt-PCR test for other viruses (adenovirus, metapneumovirus, picornavirus, respiratory syncytial virus, influenza et parainfluenza and other coronavirus strains)
|
at 42 days
|
comparison of inflammatory response level between different coronavirus strains
Tidsram: at 42 days
|
measure of level of the two inflammation biomarkers (IFIT1 interferon and CCL8)
|
at 42 days
|
Estimation of medico-social risk factors associated with COVID-19 infection
Tidsram: at 42 days
|
measure of the medico-social relative risk associated with rt-PCR COVID-19 test positivity among : school level, gender, school type, day care facilities before 11th May, number of siblings, housing type, number of bedrooms, precariousness level, by score EPICES ( (Evaluation de la Précarité et des Inégalités de santé dans les Centres d'examens de santé, means Assessment of precariousness and health inequalities in health examination centers). Questionnaire of EPICES counts 11 items, the answer to each question is assigned a coefficient, the sum of the 11 answers gives the score EPICES. The score is continuous, it varies from 0 (lack of precariousness) to 100 (maximum precariousness). |
at 42 days
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Förväntat)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 20-HPNCL-02
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Infection; Viral, Coronavirus
-
Instituto Nacional de Ciencias Medicas y Nutricion...AvslutadCoronavirusinfektioner | Covid-19 | Viral lunginflammation mänskligt coronavirusMexiko
-
Institut PasteurRekrytering
-
Federico II UniversityOkänd
-
Semmelweis University Heart and Vascular CenterUniversity of Pecs; Semmelweis University; Szeged University; University of...Okänd
-
National Institutes of Health Clinical Center (CC)IndragenAnvändbarheten av empiriska antibiotika för icke-intuberade nya Coronavirus-sjukdomar 2019-patienterCoronavirus-infektion | Lunginflammation | Covid19Förenta staterna
-
Fundación Pública Andaluza para la gestión de la...Spanish Network for Research in Infectious Diseases; Grupo de Estudio de...AvslutadTransplantationsmottagare | Infektioner, CoronavirusSpanien
-
Tasly Pharmaceuticals, Inc.IndragenCoronavirus-sjukdom 2019 | Ny lunginflammation av coronavirus
-
ProgenaBiomeDSCS CRORekryteringCovid-19 | Coronavirus-infektion | COVID | Coronavirus-infektion | Coronavirus | SARS-CoV-2 | Coronavirus-19 | Coronavirus 19Förenta staterna
-
Tychan Pte Ltd.AvslutadCoronavirus Disease-2019 (COVID-19)Singapore
-
I-Mab Biopharma Co. Ltd.AvslutadCoronavirus sjukdom 2019 COVID-19Förenta staterna
Kliniska prövningar på RT-PCR Covid-19
-
University Hospital, LilleRekryteringCovid19 | SARS-CoV-infektionFrankrike
-
Centre Hospitalier Universitaire, AmiensUniversity Hospital, Rouen; University Hospital, Montpellier; Central Hospital... och andra samarbetspartnersAktiv, inte rekryterandeCovid-19 | Hepatocellulärt karcinomFrankrike
-
University Hospital, LilleRekrytering
-
Assaf-Harofeh Medical CenterAvslutad
-
Assiut UniversityAvslutadBedöm resultatet för barn med Covid-19 inlagda på Assuit University Children HospitalEgypten
-
University of RochesterEunice Kennedy Shriver National Institute of Child Health and Human Development...Aktiv, inte rekryterandeCovid19Förenta staterna
-
PfizerCVS CaremarkAvslutad
-
BioTeke USA, LLCCSSi Life SciencesAvslutad
-
EDP BiotechParagon Rx Clinical, Inc.; iCura Diagnostics, LLCAvslutadCovid-19 | SARS-CoV-2-infektionFörenta staterna
-
Bangladesh Medical Research Council (BMRC)OkändHög känslighet och specificitet (med 95 % konfidensintervall) för RealDetect™ COVID-19 RT-PCR KitBangladesh